Mirae Asset Global Etfs Holdings Ltd. Arbutus Biopharma Corp Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $41.5 Billion
- Q3 2024
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Arbutus Biopharma Corp stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 81,089 shares of ABUS stock, worth $281,378. This represents 0.0% of its overall portfolio holdings.
Number of Shares
81,089
Previous 65,080
24.6%
Holding current value
$281,378
Previous $201,000
55.22%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding ABUS
# of Institutions
156Shares Held
99.6MCall Options Held
2.31MPut Options Held
525K-
Morgan Stanley New York, NY21.7MShares$75.3 Million0.01% of portfolio
-
Whitefort Capital Management, LP New York, NY12.9MShares$44.7 Million26.34% of portfolio
-
Black Rock Inc. New York, NY11.6MShares$40.1 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.92MShares$30.9 Million0.0% of portfolio
-
Two Seas Capital LP Rye, NY8.39MShares$29.1 Million10.86% of portfolio
About Arbutus Biopharma Corp
- Ticker ABUS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 149,951,008
- Market Cap $520M
- Description
- Arbutus Biopharma Corporation, a biopharmaceutical company, develops novel therapeutics for chronic Hepatitis B virus (HBV) infection, SARS-CoV-2, and other coronaviruses in the United States. Its HBV product pipeline consists of AB-729, a proprietary subcutaneously delivered RNA interference product candidate, which in Phase Ia/Ib clinical tria...